Revascularization Guidelines Series-Panel Discussion 1

Video Transcription

Video Summary

In this video transcript, clinicians discuss the challenges of determining the appropriate duration of pharmaceutical therapy for patients at risk of bleeding and ischemic events. They suggest a personalized approach based on individual patient risk factors and emphasize the importance of considering bleeding and ischemic risks together. They also mention the potential role of artificial intelligence and machine learning in guiding treatment decisions. The clinicians highlight the complexity of the topic and the need for ongoing research and collaboration among healthcare professionals. Some discussion is also had regarding the use of imaging in PCI procedures, with the conclusion that it is most useful for high-risk lesions and complex cases. No specific credits are given.

Keywords

pharmaceutical therapy

bleeding

ischemic events

personalized approach

artificial intelligence